Millions of Americans who suffer from insulin-dependent diabetes might eventually be able to treat the disease by consuming capsules of insulin produced by genetically modified lettuce. Researchers at
Lettuce was chosen because it is inexpensive to grow and avoids the negative stigma associated with tobacco. Although the insulin would be produced in lettuce, the chemical would be administered to humans in capsule form because the dosage must be controlled carefully.
Professor of molecular biology and microbiology Henry Daniell said research results indicate that the insulin capsules could someday be used to prevent diabetes before symptoms appear and to treat the disease in its later stages.
Nearly 21 million Americans, about 7 percent of the population, have Type 1 or 2 diabetes, according to the American Diabetes Association.
{sidebar id=1}
For more: Henry Daniell,
Latest from Garden Center
- University of Florida study unlocks secrets of invasive short-spined thrips
- Kian-backed Eden Brothers adds Michael Hollenstein as CEO, expands senior leadership team
- IPPS announces organizational rebrand, new website and 2026 international membership drive
- Growscape appoints chief manufacturing officer, Brian Cunningham
- Experts help Florida cemetery become state’s first to earn arboretum accreditation
- Fresh Inset appoints Gordon Robertson as general manager, North America
- Society of American Florists planning fifth annual Next Gen LIVE! conference for young floral professionals
- Applications now open for American Floral Endowment graduate scholarships